🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Technology Sector SEC Filings — May 27, 2026

The 32 filings for the S&P 500 Technology stream reveal a sector bifurcated between AI-driven growth leaders and companies facing margin pressure from acquisition integration and restructuring. Salesforce and Snowflake posted strong revenue beats (13% and 33% YoY, respectively), but both guided for deceleration, signaling a potential top in growth rates. Synopsys reported a 42% revenue surge from the Ansys acquisition, but GAAP net income collapsed 95% due to massive amortization and restructuring charges, highlighting the cost of M&A-driven growth. Insider activity is sparse, but the appointment of an activist investor (Elliott) to Synopsys' board signals a push for operational efficiency. A significant risk flag is the unsolicited tender offer for Genco Shipping, where less than 1% of shares have been tendered despite a raised offer, indicating shareholder skepticism. The most actionable opportunity is Salesforce's massive $25B ASR, which, combined with its record margins, suggests management sees the stock as undervalued. Sector-wide, capital allocation is shifting from reinvestment to shareholder returns, with buybacks and dividends dominating, while M&A integration costs are creating earnings headwinds.

8 high priority 24 medium 32 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 27, 2026

The May 27, 2026, filing batch for the NASDAQ-100 stream is dominated by routine corporate actions (AGM results, debt offerings, and delayed 13F filings), but two high-conviction themes emerge: a hostile takeover battle in the dry bulk shipping sector and a strategic CEO appointment at a late-stage biotech. Genco Shipping & Trading is the focal point, with Diana Shipping raising its hostile bid to $24.80/share (a 39% premium) while facing near-zero shareholder tenders (0.0002% of shares), setting up a critical proxy fight at the June 18 AGM. In biotech, Immunic's appointment of a Genentech/Roche veteran as CEO, with a pivotal Phase 3 data readout and potential NDA filing by year-end, presents a high-risk/high-reward catalyst. The remaining filings are largely low-materiality, with eight delayed 13F filings from Kentucky Farm Bureau (2016-2018) offering no current trading insights, and several AGM results showing minor shareholder dissent (6-23% withhold votes) but no material impact. Capital allocation signals are mixed: Apple Hospitality REIT extended a $242.5M buyback, while Murphy USA issued $500M in new 5.875% debt, indicating a refinancing or growth capex need.

4 high priority 25 medium 29 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 27, 2026

The 50 filings from S&P 500 Financials and adjacent sectors reveal a broad divergence between companies with robust growth and those in distress. Notably, Dycom Industries and Marvell Technology reported exceptional revenue growth (+56% and +28% YoY, respectively) driven by acquisitions and AI demand, while Trillion Energy and Hi-Great Group posted massive losses. Capital allocation trends show a split: Movado raised dividends 14%, while Dick's Sporting Goods cut buybacks 53% amid acquisition integration. Insider activity was limited, but Nukkleus faces Nasdaq delisting, and several biotechs (Apogee, Immunic) advanced pivotal catalysts. M&A activity is picking up, with Worthington Steel cleared to close its German acquisition and GameStop's bold $125/share bid for eBay. Portfolio-level patterns indicate that operational efficiency is under pressure, with Home Depot and Abercrombie & Fitch seeing margin compression despite revenue gains. Overall, the data suggests investors should favor names with clear growth catalysts and vigilant cash management, while avoiding firms with going-concern risks or unprofitable core operations.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 27, 2026

The 50 filings for the S&P 500 Consumer Staples stream reveal a sector bifurcated between defensive stability and operational restructuring. While core consumer names like **Movado Group** show robust top-line growth (8.1% YoY) and margin expansion (+320 bps), others like **Monro, Inc.** are navigating significant store closures and sales declines (-7.2% YoY) to improve profitability. A key theme is capital discipline, with **Movado** raising its dividend by 14% and **Molson Coors** executing a $2.5B debt refinancing, contrasting with **Nature's Miracle**'s near-total revenue collapse (96% YoY). Notable activist resolution at **lululemon** with founder Chip Wilson adds a governance catalyst. The most material event is the $3.8B SPAC merger for solid-state battery developer **ProLogium**, signaling a major bet on next-gen energy storage. Overall, the sector presents a 'show-me' story where cost-cutting and balance sheet management are driving near-term results, while top-line growth remains uneven and heavily dependent on specific product cycles and foreign exchange.

19 high priority 31 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 27, 2026

The 50 filings from the S&P 500 Industrials stream reveal a market bifurcated between growth-oriented companies (energy transition, infrastructure, and biotech) and consumer-facing firms experiencing demand softness. Revenue growth is present across 6 of 10 reporting companies, with AMSC (+34% YoY) and Transcat (+19% YoY) leading, but margin compression is a pervasive theme—Home Depot (-120 bps OM), Bath & Body Works (-280 bps GM), Transcat (-240 bps OM), and G-III Apparel (not reported) all show cost pressures eating into profitability. Capital markets remain active: two major SPAC mergers (ProLogium at $3.8B, Stellar/Prosperity) and a $3.5B take-private (Veris Residential) highlight deal flow, while Apogee secured $1.3B in non-dilutive financing. Insider signals are sparse but notable—Jessica Alba at Honest Company received 55% withheld votes, a potential governance red flag. The overarching theme is that industrial companies tied to grid modernization (AMSC, Oncor) and defense/energy infrastructure are outperforming traditional retail and office REITs, with forward guidance generally cautious (Bath & Body Works maintains negative sales outlook, Phreesia kept revenue range flat despite 13% growth).

28 high priority 22 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 27, 2026

The five filings for the S&P 500 Energy stream on May 27, 2026, present a mixed but actionable picture. The most material development is Cheniere Energy's $1.75 billion debt refinancing, where the subsidiary is issuing new notes at higher coupons (5.350% and 6.050%) to redeem $1.5 billion in 5.00% notes due 2027, reflecting a significant increase in long-term borrowing costs (+35 to +105 bps). This is a clear signal of rising interest rate pressure on energy infrastructure debt. Meanwhile, Cheniere Energy Partners (CQP) announced a separate, unregistered offering, creating potential confusion about the total debt stack. The Copper Property Trust filing is purely procedural, offering no new financial data. IIOT-OXYS, a micro-cap, continues to show financial distress with its seventh extension of a $75,000 convertible note, pushing maturity to October 2026. The Capasso Planning Partners 13F reveals a conservative, fixed-income-heavy portfolio with minimal direct energy exposure, suggesting institutional caution. The dominant theme is capital structure management in a high-rate environment, with no period-over-period growth data or insider activity to offset the refinancing cost pressures.

3 high priority 2 medium 5 total filings
· daily

US Material Events SEC 8-K Filings — May 27, 2026

The 50 filings reveal a market bifurcated between capital-intensive growth plays and defensive restructuring. Key themes include a surge in non-dilutive and alternative financing (Apogee, Bit Digital, WhiteFiber), SPAC activity (Translational Development/Oceanhawk), and significant insider/board changes signaling strategic pivots (lululemon, Synopsys, Immunic). Period-over-period data shows mixed consumer health: Bath & Body Works reported a 3% YoY revenue decline and 280 bps gross margin compression, while Agilent posted 10% revenue growth and 130 bps margin expansion. Capital allocation trends are defensive, with debt refinancings (Molson Coors, Oncor) and ATM offerings (Data Storage, Callan JMB, Minerva) common. Notable M&A includes Veris Residential's $3.5B take-private and BuzzFeed's $120M majority stake sale. Forward-looking statements highlight key catalysts: Immunic's Phase 3 RMS data (YE2026), ProLogium's SPAC merger (H2 2026), and Apogee's milestone-driven $1.3B financing. Insider activity is limited, but board appointments at Synopsys (Elliott partner) and lululemon (activist settlement) signal governance shifts. Overall, the digest points to a market favoring companies with clear catalysts and strong balance sheets, while consumer-facing and early-stage biotech face headwinds.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 27, 2026

The 50 filings for the Dow 30 stream reveal a bifurcated earnings landscape: while technology leaders like Salesforce and Marvell deliver record revenue and surging AI-driven growth, consumer-facing names like Bath & Body Works and U-Haul show clear signs of demand softening and margin compression. A dominant theme is the aggressive pivot toward AI and data infrastructure, with Salesforce's Agentforce ARR surging over 200% YoY and Marvell raising its outlook on AI demand, even as capital allocation shifts heavily toward buybacks and debt financing. Several filings highlight significant insider activity and governance changes, including a notable retraction of a credit facility announcement from Fold Holdings and a major $3.5B take-private acquisition of Veris Residential. Period-over-period comparisons reveal a mixed picture: revenue growth is present but often comes at the cost of compressed margins (e.g., Home Depot's sales up 4.8% but operating income down 3.0%), while capital markets activity remains robust with large debt issuances from Oncor and Molson Coors. The overall sentiment is cautiously optimistic, with clear winners in AI and infrastructure, but growing risks in consumer discretionary and real estate segments.

21 high priority 29 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 27, 2026

The May 27, 2026 filings reveal a bifurcated market: large-cap retailers like Home Depot and Dick's Sporting Goods show revenue growth but margin compression, while small-cap companies like GridAI and Trillion Energy face severe financial distress. Notable M&A activity includes Worthington Steel's clearance for Klöckner acquisition and GameStop's non-binding bid for eBay. Biotech Apogee Therapeutics reported strong Phase 2 data and secured $1.3B non-dilutive financing, while Precision BioSciences showed promising HBV data with safety concerns. Insider activity is limited, but capital allocation trends show dividend increases at Movado and G-III Apparel, while many small caps rely on ATM offerings. The overall theme is selective strength in established companies versus cash-burning small caps.

20 high priority 30 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 27, 2026

The 50 filings from the S&P 500 Consumer Discretionary sector reveal a sector bifurcating between winners and laggards. Home Depot posted revenue growth (+4.8% YoY) but operating income fell 3%, while Abercrombie & Fitch recorded record Q1 sales but saw both comparable sales and margins decline. In contrast, Marvell Technology and Salesforce delivered standout results with 28% and 13% YoY revenue growth respectively, driven by AI adoption, but both face deceleration risks. Insider and capital allocation signals are sparse but notable: BuzzFeed's majority sale to Byron Allen at $3/share, Fold Holdings retracting a credit facility claim, and Willis Lease Finance failing a supermajority vote on a stock split all signal stress in smaller names. A significant cluster of late-filed 13Fs from Kentucky Farm Bureau Mutual Insurance (reporting 2016-2018 holdings) suggests no current portfolio relevance. Several SPAC and micro-cap governance filings add noise. The most actionable themes are: AI-driven growth in tech-discretionary names (Marvell, Salesforce), real estate and credit fund liquidity events (First Realty NJ sale for $28.8M, Oaktree/StepStone/BlackRock private credit steady NAVs), and financial distress signals in Pacific Oak REIT (default lawsuit) and Borealis Foods (delisting risk). Overall, the sector shows low single-digit core growth with margin pressure, but AI and specialty finance offer alpha generation opportunities.

11 high priority 39 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 27, 2026

The 39 filings from the S&P 500 Healthcare sector reveal a sector bifurcated between established players showing operational discipline and early-stage entities facing existential capital and legal challenges. Period-over-period data shows strong revenue growth at **nCino** (10.6% YoY) and **Citi Trends** (14.4% YoY), with the latter more than doubling its Adjusted EBITDA, while **Pacira BioSciences** highlights record revenues ($726.4M) and a successful proxy defense. However, significant risk is concentrated in **Pacific Oak Strategic Opportunity REIT** (facing an $80M default lawsuit), **Artelo Biosciences** (FINRA arbitration claim), and **Minerva Neurosciences** (dilutive $75M ATM offering). A major sector-defining event is the overwhelming shareholder approval (98.9% for) of **Webster Financial's** acquisition by Banco Santander, despite significant dissent on executive compensation. The most actionable forward-looking catalyst is **NewHold Investment Corp. III's** $2.4B merger with Newcleo, a nuclear technology firm with a $220M oversubscribed PIPE, offering a unique, albeit high-risk, exposure to next-gen energy. Overall, the sector shows a clear pattern of capital flowing towards de-risked, cash-flow-positive businesses while speculative, pre-revenue entities face a more challenging funding environment.

17 high priority 22 medium 39 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 27, 2026

This batch of 12 proxy filings reveals a landscape dominated by corporate actions that carry significant shareholder implications, ranging from redomiciliation and dilutive capital raises to SPAC business combinations and governance shifts. A key theme is the prevalence of 'mixed' sentiment filings (Gates Industrial, Nukkleus, Translational Development), where management proposes actions that offer strategic benefits but simultaneously introduce risks like dilution or reduced shareholder protections. Period-over-period comparisons are largely absent from the provided enriched data, limiting trend analysis, but forward-looking statements and transaction details are rich with actionable intelligence. The most critical developments are the high-risk SPAC deal for Live Oak Acquisition Corp. V (no fairness opinion, no redemption threshold) and the dilutive capital raises at Nukkleus and Caring Brands, which demand immediate investor attention. Insider trading activity is not explicitly detailed in the enriched data, but management conviction can be inferred from board recommendations and the structure of proposed transactions. The portfolio-level pattern is one of capital-seeking entities (SPACs, small-cap biotechs) using shareholder votes to secure survival or growth, while more established firms (Gates Industrial, Capital Southwest) focus on governance optimization and routine matters.

12 high priority 12 total filings
· daily

US IPO Pipeline SEC S-1 Filings — May 27, 2026

The IPO pipeline is dominated by three distinct capital-raising events and one transformative exchange offer, signaling a bifurcated market where distressed companies seek emergency funding while growth platforms execute strategic acquisitions. LiqTech International's S-1 reveals acute cash needs, with $1.1M in high-discount notes issued just two months before the offering, while urban-gro's S-1 marks a radical pivot from a discontinued agriculture business to a cricket media platform, creating valuation uncertainty. SoundHound AI's S-4 for LivePerson acquisition introduces a collar mechanism that caps stock consideration, reflecting market volatility concerns, while HBT Financial's exchange offer is a routine debt management move. Period-over-period data from the enriched filings shows no direct revenue or margin trends across the set, but insider activity is notably absent, and forward-looking guidance is limited to deal timelines. The most critical development is urban-gro's complete business transformation, which carries a materiality score of 10/10 and demands immediate investor attention.

4 high priority 4 total filings
· daily

Global High-Priority Regulatory Events — May 27, 2026

This digest synthesizes 50 high-priority filings from May 27, 2026, revealing a market dominated by financial distress signals and major strategic pivots. A significant cluster of insolvency and regulatory non-compliance filings (Ansal Properties, Impex Ferro Tech, Unitech International, Quadrant Televentures, Shree Hanuman Sugar) underscores severe stress in Indian industrial and real estate sectors, with multiple companies in CIRP and facing fines for board composition failures. Conversely, high-stakes M&A activity is reshaping the energy and technology landscapes, with NextEra's proposed acquisition of Dominion Energy and GameStop's audacious bid for eBay signaling a potential wave of transformative deals. Period-over-period data reveals a stark divergence: while Home Depot and Gandhar Oil Refinery show resilient revenue growth (4.8% and 8.8% YoY respectively), deep value destruction is evident at Trillion Energy (revenue down 58.9% YoY, net loss widening to $49.2M) and Hi-Great Group (revenue down 46.6% YoY, cash nearly depleted). The most critical development is the confluence of a major SPAC merger (ProLogium at $3.8B valuation) and a massive biotech financing (Apogee's $1.3B deal with Blackstone), highlighting a market that is simultaneously funding innovation while punishing weak balance sheets. Portfolio-level patterns indicate a 'flight to quality' with capital flowing to companies with clear catalysts and strong insider conviction, while companies with governance lapses or deteriorating fundamentals face rapid de-rating.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — May 27, 2026

The 41 filings reveal a bifurcated earnings season. While top-line growth is present across several sectors (Home Depot +4.8%, Box +10.7%, AMSC +34.3%, Synopsys +41.9%), margin compression and rising costs are a dominant theme, with 5 of 16 new filings showing operating income declines despite revenue growth. The most acute distress is concentrated in micro-cap companies like Hi-Great Group (revenue -46.6%, cash near zero) and Nature's Miracle (revenue -96%), while larger firms like Modine and U-Haul face operational headwinds from depreciation and restructuring charges. Insider activity is notably absent from the enriched data, but capital allocation patterns show aggressive buybacks at Box ($115M in quarter) and Synopsys ($262.5M), contrasted with dividend increases at StepStone (+37% YoY). The 25 CarMax trust filings are procedural and carry no actionable intelligence. The most compelling opportunities lie in AMSC's 34% revenue growth with a swing to profitability, Semtech's 37% net income growth, and nCino's operational leverage (swung from -$1.5M to +$21.1M operating income).

41 high priority 41 total filings
· daily

US SEC Trading Suspension Halt Orders — May 27, 2026

The five filings for May 27, 2026, reveal a severe cluster of Nasdaq non-compliance events, with all five companies receiving deficiency notices for late filings, low market values, or insufficient equity. This concentration of regulatory risk suggests a broader market trend of small-cap distress, likely driven by tight financing conditions and operational challenges. Period-over-period comparisons are not directly available for these specific filings, but the recurrence of late filings (Borealis, Greenwave) and the failure to regain compliance after initial notices (Liminatus, SOBR Safe) indicate deteriorating financial controls and liquidity. The most critical development is the potential delisting of Liminatus Pharma, which has exhausted its compliance period and is now in a high-stakes appeal. The market implications are significant: investors face heightened delisting risk, potential trading halts, and severe share price volatility across these names. The portfolio-level pattern is a clear 'delisting wave' in the micro-cap space, with no bullish signals and a uniform negative sentiment across all filings.

5 high priority 5 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 27, 2026

The 50 filings from May 27, 2026, paint a stark picture of a bifurcated market: a wave of distressed micro-caps is aggressively seeking emergency capital through dilutive ATMs, convertible notes, and private placements, while larger, more stable companies are opportunistically refinancing debt and pursuing strategic M&A. The most critical theme is the surge in Nasdaq non-compliance and going-concern risks, with at least five companies (Borealis Foods, Greenwave Technology, Liminatus Pharma, SOBR Safe, Callan JMB) facing potential delisting. This distress is concentrated in the small-cap biotech and technology sectors, where cash burn and failed trials are forcing existential restructuring. In contrast, the energy and digital infrastructure space is seeing significant capital deployment, highlighted by DigitalBridge's $1.05B acquisition of ArcLight and newcleo's $2.4B SPAC merger. Insider activity is notably absent from these filings, but capital allocation patterns—aggressive dilution vs. strategic debt refinancing—clearly separate the survivors from the distressed. The period-over-period data from BDCs (Golub Capital, PennantPark) shows flat-to-declining net asset values, signaling a cautious outlook for credit markets. The most actionable intelligence lies in the distressed names where the structure of rescue financing (e.g., HWH International's control-diluting deal) creates both extreme risk and potential for asymmetric returns.

50 high priority 50 total filings
· daily

US Executive Officer Management Changes SEC — May 27, 2026

The 32 filings reveal a dynamic period for US executive and director changes, marked by significant leadership transitions at key companies like Bath & Body Works, Immunic, and Braze, alongside routine governance updates. A notable trend is the high frequency of CFO changes, with six filings (Bath & Body Works, Arq, Rollins, Braze, Six Flags, and Zurn Elkay) involving CFO appointments or departures, signaling potential strategic pivots or operational challenges. Period-over-period comparisons show a mixed financial landscape: Agilent and Braze reported strong revenue growth (10% and 30.2% YoY, respectively), while Bath & Body Works saw a 3% sales decline and margin compression. Insider activity was limited, but significant shareholder dissent was observed at Honest Company and Xerox, indicating governance concerns. Forward-looking statements from Immunic (pivotal Phase 3 data) and Braze (continued acceleration) offer catalysts, while guidance reaffirmation at Bath & Body Works and raised guidance at Agilent provide contrasting outlooks. Overall, the filings suggest a market in transition with both opportunities and risks concentrated in specific sectors like biotech and consumer goods.

32 high priority 32 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 27, 2026

The 32 filings from May 27, 2026, reveal a bifurcated market where strong operational performance at Agilent and Braze contrasts with consumer-facing weakness at Bath & Body Works. Board room changes are dominated by routine governance (annual meetings, equity plan approvals) and leadership transitions, with notable CEO appointments at Immunic (pre-commercial biotech) and Kemper (insurance turnaround). A key theme is the high level of shareholder dissent on equity dilution, with Xerox (25.5% against) and Dermata (low 'For' votes) flagging governance risk. Insider activity is limited, but the CFO departures at Bath & Body Works and Rollins introduce transition risk. Period-over-period data shows a mixed picture: Agilent's 10% revenue growth and margin expansion contrast with Bath & Body Works' 3% sales decline and 280 bps gross margin compression. The most critical developments are the high-stakes catalyst at Immunic (Phase 3 data readout) and the significant management overhaul at Braze, which accompanies strong revenue growth but margin pressure.

32 high priority 32 total filings
· daily

US Merger & Acquisition SEC Filings — May 27, 2026

The US M&A landscape on May 27, 2026, reveals a market bifurcated between high-conviction, high-value transactions and distressed SPACs facing existential regulatory and financial pressures. The most significant development is the $3.8 billion de-SPAC merger between ProLogium and TDAC, a high-risk/high-reward play in next-gen battery technology, while the completed $3.5 billion take-private of Veris Residential demonstrates strong private equity appetite for real assets. However, a troubling pattern emerges among SPACs: three entities (Charlton Aria, ASPAC III, Flag Ship) have received Nasdaq deficiency notices for late filings or low equity, signaling systemic operational and compliance failures. The Live Oak-Teamshares deal introduces significant governance risk by proceeding without a fairness opinion or redemption threshold. Capital markets remain open for new SPAC IPOs, with Oceanhawk and Amanat raising a combined $235 million, indicating continued sponsor appetite despite the sector's headwinds. The overall sentiment is mixed, with a clear divergence between well-capitalized, execution-focused deals and a cohort of struggling blank-check companies.

10 high priority 10 total filings